Immunopathology in PMM2-CDG: Defective glycosylation impact in the TNFα -TNFR1 signalling pathway. [PDF]
Pascoal C +12 more
europepmc +1 more source
Zscan4 as a Candidate Conveyor of Early Developmental Defects in O-GlcNAc Transferase Intellectual Disability. [PDF]
Pravata VM +4 more
europepmc +1 more source
Zebrafish models for congenital disorders of glycosylation (CDG): a systematic review. [PDF]
Gandoy-Fieiras N +2 more
europepmc +1 more source
A cyclic di-GMP phosphodiesterase in the VSP-2 island of <i>Vibrio cholerae</i> is regulated by zinc and quorum sensing. [PDF]
Rangarajan AA +5 more
europepmc +1 more source
<i>In vitro</i> cell model to dilucidate the underlying molecular mechanism associated with ophthalmic manifestation of congenital disorders of glycosylation: studying an ALG2-CDG patient. [PDF]
Cubilla MA +3 more
europepmc +1 more source
Antibody-conjugated mesenchymal stromal cell drug delivery system for the treatment of autoimmune diseases in mice. [PDF]
Xie Q +8 more
europepmc +1 more source
Suspected Central Adrenal Insufficiency in a Patient with Phosphomannomutase 2-Congenital Disorder of Glycosylation. [PDF]
Ødum SF +3 more
europepmc +1 more source
Treatment of Single Patient With PMM2-Congenital Disorder of Glycosylation With Govorestat (AT-007), an Aldose Reductase Inhibitor. [PDF]
Jalazo ER +4 more
europepmc +1 more source
Advancement in Clinical Glycomics and Glycoproteomics for Congenital Disorders of Glycosylation: Progress and Challenges Ahead. [PDF]
Abu Bakar N, Hamzan NI.
europepmc +1 more source
Bleeding Disorders in Children With Genetic Diseases: A Narrative Review. [PDF]
Cagol R +6 more
europepmc +1 more source

